PlainRecalls
FDA Drug Low Class III Terminated

Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.

Reported: November 8, 2017 Initiated: October 13, 2017 #D-0056-2018

Product Description

Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.

Reason for Recall

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Units Affected
422 vials
Distribution
Nationwide in the USA
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.. Recalled by Sanofi-Aventis U.S. LLC. Units affected: 422 vials.
Why was this product recalled?
Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 8, 2017. Severity: Low. Recall number: D-0056-2018.